Want to see NHTC full AI Analyst Report?
Natural Health Trends (NHTC) Ratios
258 Followers
Natural Health Trends Ratios
NHTC's free cash flow for Q3 2026 was $-1.10M. For the 2026 fiscal year, NHTC's free cash flow was decreased by $-7.00K and operating cash flow was $-1.09M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.50 | 2.45 | 3.21 | 3.79 | 3.79 |
| Quick Ratio | 2.35 | 2.29 | 3.00 | 3.57 | 3.58 |
| Cash Ratio | 0.50 | 0.65 | 2.81 | 3.41 | 3.40 |
| Solvency Ratio | -0.05 | 0.03 | 0.03 | 0.02 | 0.04 |
| Operating Cash Flow Ratio | -0.44 | -0.16 | -0.21 | -0.24 | 0.04 |
| Short-Term Operating Cash Flow Coverage | -6.90 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 19.20M | $ 28.50M | $ 36.74M | $ 44.88M | $ 54.60M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.08 | 0.05 | 0.05 | 0.05 | 0.03 |
| Debt-to-Equity Ratio | 0.13 | 0.08 | 0.08 | 0.08 | 0.05 |
| Debt-to-Capital Ratio | 0.12 | 0.07 | 0.08 | 0.08 | 0.05 |
| Long-Term Debt-to-Capital Ratio | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.64 | 1.68 | 1.66 | 1.65 | 1.65 |
| Debt Service Coverage Ratio | -0.89 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.27 | 0.23 | 0.30 | 0.36 | 0.29 |
| Net Debt to EBITDA | 8.04 | -14.50 | 34.98 | 993.08 | -43.14 |
| Profitability Margins | |||||
| Gross Profit Margin | 73.54% | 73.98% | 74.56% | 74.23% | 74.99% |
| EBIT Margin | -1.43% | 1.44% | -3.80% | -0.55% | 2.62% |
| EBITDA Margin | -1.15% | 1.75% | -3.43% | -0.13% | 3.12% |
| Operating Profit Margin | -4.55% | -3.02% | -3.80% | -0.55% | 2.62% |
| Pretax Profit Margin | -1.43% | 1.44% | 1.70% | 1.23% | 2.52% |
| Net Profit Margin | -2.22% | 1.33% | 1.29% | 0.64% | 1.81% |
| Continuous Operations Profit Margin | -2.22% | 1.33% | 1.29% | 0.64% | 1.81% |
| Net Income Per EBT | 155.56% | 92.26% | 76.24% | 51.99% | 71.85% |
| EBT Per EBIT | 31.36% | -47.73% | -44.58% | -222.96% | 96.12% |
| Return on Assets (ROA) | -2.30% | 1.03% | 0.82% | 0.38% | 1.10% |
| Return on Equity (ROE) | -3.76% | 1.74% | 1.37% | 0.62% | 1.82% |
| Return on Capital Employed (ROCE) | -7.31% | -3.76% | -3.40% | -0.43% | 2.13% |
| Return on Invested Capital (ROIC) | -7.06% | -3.36% | -2.54% | -0.22% | 1.51% |
| Return on Tangible Assets | -2.30% | 1.03% | 0.82% | 0.38% | 1.10% |
| Earnings Yield | -2.48% | 1.08% | 0.85% | 0.80% | 1.46% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 18.96 | 12.49 | 11.29 | 15.63 | 19.72 |
| Inventory Turnover | 5.14 | 3.42 | 2.60 | 2.80 | 2.86 |
| Fixed Asset Turnover | 19.67 | 15.98 | 12.25 | 11.20 | 17.22 |
| Asset Turnover | 1.04 | 0.78 | 0.64 | 0.59 | 0.61 |
| Working Capital Turnover Ratio | 1.57 | 1.15 | 0.87 | 0.78 | 0.82 |
| Cash Conversion Cycle | 51.75 | 77.62 | 107.88 | 107.10 | 109.33 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 71.00 | 106.84 | 140.22 | 130.45 | 127.84 |
| Days of Payables Outstanding | 19.25 | 29.22 | 32.34 | 23.35 | 18.51 |
| Operating Cycle | 71.00 | 106.84 | 140.22 | 130.45 | 127.84 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.52 | -0.29 | -0.37 | -0.43 | 0.09 |
| Free Cash Flow Per Share | -0.53 | -0.30 | -0.38 | -0.44 | 0.07 |
| Dividend Paid and CapEx Coverage Ratio | -0.65 | -0.36 | -0.46 | -0.52 | 0.11 |
| Capital Expenditure Coverage Ratio | -88.19 | -59.07 | -93.00 | -33.93 | 4.52 |
| Operating Cash Flow Coverage Ratio | -1.92 | -1.27 | -1.23 | -1.18 | 0.32 |
| Operating Cash Flow to Sales Ratio | -0.15 | -0.08 | -0.10 | -0.10 | 0.02 |
| Free Cash Flow Yield | -17.07% | -6.46% | -6.45% | -12.82% | 1.06% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -40.29 | 92.59 | 117.98 | 124.51 | 68.64 |
| Price-to-Sales (P/S) Ratio | 0.89 | 1.23 | 1.53 | 0.79 | 1.24 |
| Price-to-Book (P/B) Ratio | 1.52 | 1.61 | 1.61 | 0.78 | 1.25 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -5.86 | -15.47 | -15.50 | -7.80 | 94.15 |
| Price-to-Operating Cash Flow Ratio | -5.92 | -15.73 | -15.67 | -8.03 | 73.30 |
| Price-to-Earnings Growth (PEG) Ratio | 0.16 | 230.07 | 1.47 | -1.73 | 2.83 |
| Enterprise Value Multiple | -69.52 | 56.04 | -9.49 | 402.60 | -3.32 |
| Enterprise Value | 31.84M | 42.09M | 14.30M | -26.57M | -6.20M |
| EV to EBITDA | -69.52 | 56.04 | -9.49 | 402.60 | -3.32 |
| EV to Sales | 0.80 | 0.98 | 0.33 | -0.54 | -0.10 |
| EV to Free Cash Flow | -5.25 | -12.29 | -3.31 | 5.32 | -7.84 |
| EV to Operating Cash Flow | -5.31 | -12.50 | -3.34 | 5.48 | -6.10 |
| Tangible Book Value Per Share | 2.04 | 2.87 | 3.64 | 4.41 | 5.40 |
| Shareholders’ Equity Per Share | 2.04 | 2.87 | 3.64 | 4.41 | 5.40 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.56 | 0.08 | 0.24 | 0.48 | 0.28 |
| Revenue Per Share | 3.46 | 3.75 | 3.84 | 4.32 | 5.45 |
| Net Income Per Share | -0.08 | 0.05 | 0.05 | 0.03 | 0.10 |
| Tax Burden | 1.56 | 0.92 | 0.76 | 0.52 | 0.72 |
| Interest Burden | 1.00 | 1.00 | -0.45 | -2.23 | 0.96 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.78 | 0.77 | 0.36 | 0.33 | 0.30 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Income Quality | 6.80 | -5.89 | -7.53 | -15.50 | 0.94 |
Currency in USD
